1. Effectiveness of Antiemetic Regimens for Highly Emetogenic Chemotherapy‐Induced Nausea and Vomiting: A Systematic Review and Network Meta‐Analysis. (17th October 2018) Authors: Yokoe, Takamichi; Hayashida, Tetsu; Nagayama, Aiko; Nakashoji, Ayako; Maeda, Hinako; Seki, Tomoko; Takahashi, Maiko; Takano, Toshimi; Abe, Takayuki; Kitagawa, Yuko Journal: Oncologist Issue: Volume 24:Number 6(2019) Page Start: e347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Establishment of a deep‐learning system to diagnose BI‐RADS4a or higher using breast ultrasound for clinical application. Issue 10 (3rd August 2022) Authors: Hayashida, Tetsu; Odani, Erina; Kikuchi, Masayuki; Nagayama, Aiko; Seki, Tomoko; Takahashi, Maiko; Futatsugi, Noriyuki; Matsumoto, Akiko; Murata, Takeshi; Watanuki, Rurina; Yokoe, Takamichi; Nakashoji, Ayako; Maeda, Hinako; Onishi, Tatsuya; Asaga, Sota; Hojo, Takashi; Jinno, Hiromitsu; Sotome, Ke... Journal: Cancer science Issue: Volume 113:Issue 10(2022) Page Start: 3528 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Feasibility study on collecting patient‐reported outcomes from breast cancer patients using the LINE‐ePRO system. Issue 5 (26th March 2022) Authors: Hayashida, Tetsu; Nagayama, Aiko; Seki, Tomoko; Takahashi, Maiko; Matsumoto, Akiko; Kubota, Anna; Jinno, Hiromitsu; Miyata, Hiroaki; Kitagawa, Yuko Journal: Cancer science Issue: Volume 113:Issue 5(2022) Page Start: 1722 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Impact of neoadjuvant and adjuvant chemotherapy on invasive lobular carcinoma: A propensity score‐matched analysis of SEER data. Issue 9 (25th May 2020) Authors: Watanuki, Rurina; Hayashida, Tetsu; Yokoe, Takamichi; Kawai, Yuko; Kikuchi, Masayuki; Nakashoji, Ayako; Nagayama, Aiko; Seki, Tomoko; Takahashi, Maiko; Kitagawa, Yuko Journal: Breast journal Issue: Volume 26:Issue 9(2020) Page Start: 1765 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Novel antibody–drug conjugates for triple negative breast cancer. (May 2020) Authors: Nagayama, Aiko; Vidula, Neelima; Ellisen, Leif; Bardia, Aditya Journal: Therapeutic advances in medical oncology Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Sacituzumab for the treatment of triple-negative breast cancer: the poster child of future therapy?. (1st February 2019) Authors: Zangardi, Mark L.; Spring, Laura M.; Nagayama, Aiko; Bardia, Aditya Journal: Expert opinion on investigational drugs Issue: Volume 28:Number 2(2019) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The updated network meta-analysis of neoadjuvant therapy for HER2-positive breast cancer. (January 2018) Authors: Nakashoji, Ayako; Hayashida, Tetsu; Yokoe, Takamichi; Maeda, Hinako; Toyota, Tomoka; Kikuchi, Masayuki; Watanuki, Rurina; Nagayama, Aiko; Seki, Tomoko; Takahashi, Maiko; Abe, Takayuki; Kitagawa, Yuko Journal: Cancer treatment reviews Issue: Volume 62(2018) Page Start: 9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗